Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
It is not intended as a standalone therapeutic dose for severe B12 deficiency, which would require separate supplementation at different intervals and doses under veterinary guidance
availability has been significantly curtailed - No branded pharmaceutical product exists **Semaglutide:** - FDA-approved for weight management (Wegovy, 2.4 mg weekly) - FDA-approved for type 2 diabetes (Ozempic, up to 2.0 mg weekly) - Available through licensed pharmacies worldwide - Also available through 503B compounding pharmacies as a **weight loss peptide injection** - [View semaglutide products](/products/semaglutide-001) ### Injection Protocol Comparison **AOD-9604 typical research protocol:** - Dose: 250-300 mcg per injection - Frequency: Daily subcutaneous injection (fasting, typically morning) - Cycle length: 12-20 weeks - Total injections per month: ~30 **Semaglutide weight loss injection protocol:** - Starting dose: 0.25 mg weekly (4-week titration steps) - Maintenance dose: 2.4 mg weekly - Frequency: Once weekly subcutaneous injection - Total injections per month: 4 The convenience advantage is substantial
A regenerative fat-loss peptide that supports a leaner, stronger you AOD 9604 works by mimicking the way natural growth hormone stimulates fat metabolism, without raising IGF1 (Insulin-like Growth Factor 1) or triggering hormonal side effects
Studies show that sublingual (under the tongue) and nasal forms of B12 supplements offer a similar absorption rate as injections (Temova Rakua et al., 2022)
SSD soutient la rhabilitation du laboratoire du CHR de Sokod Le laboratoire du CHR de Sokod est un maillon essentiel de la chane de soins
